ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases
Marseille, France, December 04, 2019, 7:30 AM CET – ImCheck Therapeutics, a biotech [...]
Marseille, France, December 04, 2019, 7:30 AM CET – ImCheck Therapeutics, a biotech [...]
Wesel, Germany, 3 December 2019 - Clyde Bergemann Power Group (CBPG), a globally [...]
Tübingen / Kufstein, 26 November, 2019 – The medical technology and life science [...]
Waterland accelerates development of the Unified Communications as a Service (‘UCaaS’) group into [...]
Munich/Amsterdam/Brussels, 15 November 2019 – Equistone Partners Europe (“Equistone”), one of Europe’s leading [...]
Frankfurt / Trier, 5 November 2019 – Private equity firm Naxicap Partners has [...]
Münchenstein/Glattbrugg, Switzerland, 4 November 2019 – IT infrastructure provider Tineo AG, a portfolio [...]
Banks reach 54% market share in third quarter – was the end of [...]
Hamburg/Borken, Germany, 8 October 2019 – Waterland Private Equity and the founders of [...]
Munich, Germany, 01 October, 2019 – wealthpilot, a fintech company based in Munich, [...]